J pls slow down
CM [clarifying with J] GMC guidance on bridging prescriptions, we see referred to in RCGP guidance from 2016. Page 601. On the exceptionality of bridging and need to consult Good medical practice policy p5560. In an aread of undertainty the paramount principle Do no Harm? We have Bell and Tavistock decision, Cass interim and final reports. Not entirely accurate to say no guidance on use of PBs.
AD clearly lots of guidance, Cass review definitive about what to do?
CM Clearly there is a lot here, urging more caution?
AD I [can't see that?}
CM Why does the use of PBs/Xsex hormones increase when guidance urges more caution
AD I don't know
CM It appears every more by the day practice within your purview diverges from guidance?
AD I don't know national picture, no inf re prescribing so I don't know why that occured?